The enzyme shows maximum activity in the pH range of 7.0C12.0 and Ca2+(1.0C5.0mM) is required for activation [29]. to the inner membrane and extends to the exterior of the cell wall [10] where it interacts as a potent virulence factor that modulates the host immune response and plays an important role in the pathogenesis of Mtb contamination [11]. Open in a separate windows Fig 1 A. Structure of LAM. A major component of the cell envelope of Mtb is usually lipoarabinomannan (LAM). LAM is a complex of D-mannan and D-arabinan attached to a phosphatidyl-units. The arabinan consists of a linear -(15)-linked Arabackbone punctuated by branching produced by 3,5-residues. The lateral side chains are organized either as a linear tetra-arabinofuranoside or as a biantennary hexa-arabinofuranosides [13, 38]. These MK-0974 (Telcagepant) chain terminating arabinan can be further capped with short mannose -(12)-linked oligosaccharides and are epitopes for binding to mAbs used in this study. MK-0974 (Telcagepant) B. Periodic Acid Metallic Staining of Mtb CDC1551 LAM. LAM purified from produced cells showing a tight smear (MW ~ 15C17 kDa). Western blot profile of the CDC1551 LAM with the anti-LAM mouse monoclonal CS35 antibody and anti-LAM human monoclonal A194, the two antibodies used as a pair in our Capture ELISA. When purified from laboratory culture, LAMs common molecular weight is usually 15 to17 kDa and runs as a smear on SDS/PAGE. The molecule is usually heterogeneous in size (Fig 1B), branching pattern, acylation, and phosphorylation around the arabinan and mannan segments [12, 13]. LAM has been shown and validated to be present in high concentrations in biological fluids such as sputum, serum and urine [14C16]. In recent years, we and many other laboratories have made significant improvements in urinary LAM-based diagnostics for active TB [17C19]. Specimens like serum and urine collection are less invasive and can be easily collected from patients admitted to the hospital or even outside of the hospital establishing. A point-of-care (POC) test that readily detects active TB would reduce diagnostic delays, interrupt transmission with appropriate therapy, and address many of the current gaps in global TB control. Current commercial urinary LAM-based diagnostic packages have a specificity of 95% or more and sensitivity of 40C70% but are recommended only for patients with HIV and CD4 counts less than 100 cells per microliter. One such test, Alere Determine TB LAM Ag (AlereLAM), is a lateral circulation assay designed to detect LAM in urine and Rabbit Polyclonal to ARG1 used as a POC test MK-0974 (Telcagepant) for active tuberculosis [20C22]. A second test in the market, FujiLAM has been recently developed and validated [18]. This assay entails the use of two high affinity anti TBLAM monoclonal antibodies (mAb) accompanied by a silver amplification step [23] to intensify the control band and signal bands for LAM in urine, thus increasing the sensitivity of the assay compared to the AlereLAM test. We on the other hand, focused on validation of a wide range of clinical samples with a simple capture ELISA (C-ELISA) including a proteinase K (ProK) sample pretreatment [24] to alleviate background and open up epitopes if sequestered. This C-ELISA can be implemented in a clinical setting but not as a POC test. Paper have been used in analytical chemistry for centuries in the form of spot-tests, litmus paper MK-0974 (Telcagepant) and lateral circulation assays based on nitrocellulose [25C28]. Properties of paper, including low-cost, ease of fabrication, wide availability, and self-wetting, make it an ideal substrate for sensors for the developing world. In addition, properly designed immobilization can.